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When cells are migrating, caveolin-1, the principal protein
component of caveolae, is excluded from the leading edge and
polarized at the cell rear. The dynamic feature depends on a
specific sequence motif that directs intracellular trafficking of
the protein. Deletion mutation analysis revealed a putative
polarization domain at the N terminus of caveolin-1, between
amino acids 32– 60. Alanine substitution identified a minimal
sequence of 10 residues (46TKEIDLVNRD55) necessary for
caveolin-1 rear polarization. Interestingly, deletion of amino
acids 1– 60 did not prevent the polarization of caveolin-1 in
human umbilical vein endothelial cells or wild-type mouse
embryonic fibroblasts because of an interaction of Cav61–178
mutant with endogenous caveolin-1. Surprisingly, expression of
the depolarization mutant in caveolin-1 null cells dramatically
impeded caveolae formation. Furthermore, knockdown of
caveolae formation by methyl-␤-cyclodextrin failed to prevent
wild-type caveolin-1 rear polarization. Importantly, genetic
depletion of caveolin-1 led to disoriented migration, which can
be rescued by full-length caveolin-1 but not the depolarization
mutant, indicating a role of caveolin-1 polarity in chemotaxis.
Thus, we have identified a sequence motif that is essential for
caveolin-1 rear polarization and caveolae formation.

Caveolae are specific microdomains of the plasma membrane that were discovered more than 50 years ago (1). In endothelial cells, numerous vesicles appeared to derive from the uniformly flask-shaped invaginations, suggesting the endocytic
potential of caveolae (2). Although the function of caveolae as
transport vesicles mediating endocytosis and transcytosis
remained obscure (3, 4), the identification, cloning, and characterization of caveolar coat proteins, caveolins, has increased
our knowledge of caveolae, and a good body of evidence implicates caveolae in a specialized form of delivery of membrane
components, extracellular ligands, bacterial toxins, and nonen-
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veloped virus in several cell types (5– 8). The caveolae-mediated endocytic pathway differs from that mediated by clathrincoated pits. It is sensitive to protein kinase C inhibitors and
cholesterol depletion (by filipin), and in some cells it is involved
in the activation of protein tyrosine kinases (9). Phosphorylation at tyrosine 14 of caveolin-1 (Cav-1)2 may be required for
the internalization of caveolae. The mechanism controlling
caveolae trafficking remains unclear, but it apparently involves
both microtubule and actin cytoskeletons (10). Surprisingly,
using Cav-1 as a marker for caveolae, recent studies demonstrate that caveolae are rich in a variety of signaling molecules,
with the implication that caveolae may function in the regulation of signal transduction. Given these views, an attractive
hypothesis would be whether caveolae could carry signaling
machinery to different locations of the cell to spatially organize
signaling events. Indeed, Anderson and colleagues (11) have
shown recently that concomitant with the relocation of caveolae, sites of Ca2⫹ wave initiation moved to the same location in
migrating cells.
Three mammalian caveolins, i.e. Cav-1, -2, and -3, have been
identified and characterized (12). Whereas Cav-1 and -2 are
co-expressed in many cell types, Cav-3 is limited to muscle
(13–15). Cloning and sequencing of Cav-1 cDNA showed that
unlike clathrin, Cav-1 most likely is an integral membrane protein inserted into the membrane so that both the N and C termini of the protein are in the cytosol (16, 17). Biochemical studies have shown that caveolins interact with a variety of signaling
molecules, and many of these caveolin-interacting proteins
bear a common caveolin binding motif that is recognized by a
20-aa sequence (aa 82–101) proximal to the membrane insertion region. The simultaneous identification of Cav-1 as a
caveolar membrane coat and as a component of detergent
resistant trans-Golgi-derived vesicle (named VIP21, which
stands for vesicular integral membrane protein of 21 kDa)
implies that surface caveolin recycles between caveolae and the
Golgi apparatus (18). Furthermore, caveolins are implicated in
polarized vesicular traffic in epithelia (19) and in cholesterol

2

The abbreviations used are: Cav-1, caveolin-1; aa, amino acid(s); ER,
endoplasmic reticulum; HUVECs, human umbilical vein endothelial
cells; MEFs, mouse embryonic fibroblasts; GFP, green fluorescent protein; N-CPD, N-terminal caveolin polarity domain; FBS, fetal bovine
serum; M␤CD, methyl-␤-cyclodextrin; MES, 4-morpholineethanesulfonic acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
Ad, adenovirus.
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transport (20, 21). The intracellular trafficking apparently
depends on a specific amino acid sequence in caveolin (22, 23).
We and others have shown recently that caveolae and Cav-1
are polarized in migrating endothelial cells (11, 24, 25). However, the mechanism underlying the asymmetrical distribution
is not known. It is proposed that polarized caveolae and Cav-1
may play an important role in spatial organization of polarized
signaling activity during cell migration, given the fact that
caveolae are rich in signaling molecules and actively travel in
cells upon stimulation. Indeed, depolarization of Cav-1 by targeted knockdown of the protein significantly impedes cell
polarization and inhibits cell directional movement (24). In an
attempt to identify specific sequence(s) or domain(s) that controls Cav-1 rear polarization in migrating cells, we generated
mutant forms of Cav-1 fused to the reporter protein GFP and
expressed them in cells lacking endogenous Cav-1. Here, we
report the identification of a novel domain at the N terminus of
Cav-1 that controls rear polarization of the protein as well as
caveolae formation.

EXPERIMENTAL PROCEDURES
Antibodies and Reagents—pEGFP-N1 and monoclonal antibody for Cav-1 were purchased from BD Biosciences. Protein
A/G plus-agarose immunoprecipitation reagent, polyclonal
antibodies for GFP and Cav-1 (N-20) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antiFLAG M2 antibody was purchased from Sigma. Rhodamine
Red-X-conjugated secondary antibody was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA). BJ5183AD-1 electroporation-competent cells and pAdTrack-CMV
vector were generous gifts from Dr. Bert Vogelstein of The
Johns Hopkins Medical Institutions. Cell culture reagents,
LipofectamineTM 2000, and Lipofectin reagent were purchased
from Invitrogen. The bicinchoninic acid protein assay kit was
purchased from Pierce.
Cell Culture—Primary mouse embryonic fibroblasts (MEFs)
were obtained from day 13.5 mouse embryos. Pregnant mice
were sacrificed with CO2 asphyxiation. Embryos were decapitated, thoroughly minced, and trypsinized with 1 ml of 0.05%
trypsin in 0.53 mM EDTA (Invitrogen) for 20 min at 37 °C. Ten
ml of complete medium (Dulbecco’s modified Eagle’s medium)
supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin
(Invitrogen) was used to inactivate the trypsin and resuspend
the dissociated cells. Fibroblasts were plated on a 10-cm plate
and cultured in a 37 °C, 5% CO2 incubator. Early passages (passage ⬍5) of primary MEFs were used for all experiments.
Human umbilical vein endothelial cells (HUVECs) were isolated from the human umbilical vein and cultured as described
previously (24, 26). The cells were grown in MCDB131 supplemented with 5% heat-inactivated human serum, 20% heat-inactivated newborn calf serum, 150 g/ml endothelial cell
growth supplement, 5 units/ml heparin sodium, 100 units/ml
penicillin, and 100 g/ml streptomycin.
Plasmid Construction and Mutagenesis—The full-length
cDNA encoding Cav-1 or mutants was fused in-frame to the N
terminus of GFP. EcoRI and BamHI restriction sites were added
to the 5⬘ and 3⬘ ends of murine Cav-1 cDNA by PCR using the
MARCH 9, 2007 • VOLUME 282 • NUMBER 10

TripleMaster威 PCR system (Brinkmann Instruments, Inc.). A
series of mutations in Cav-1 were generated by PCR from the
cDNA of murine Cav-1 (see Fig. 1). The PCR products were
subcloned into the EcoRI and BamHI sites of the pEGFP-N1
eukaryotic expression vector (Clontech). The orientation and
sequence of Cav-1-GFP were verified by sequencing.
Cholesterol Depletion—Cholesterol depletion was performed
as described previously (27). Briefly, wild-type MEFs were incubated with 0, 3, or 10 mM methyl-␤-cyclodextrin (M␤CD) in
Dulbecco’s modified Eagle’s medium supplemented with 10%
lipid-free FBS for 30 min at 37 °C. Then, the cells were replated
onto 1 g/ml fibronectin-precoated coverglass to allow migration. After a 2-h incubation at 37 °C, cells were fixed for immunofluorescence co-staining with specific antibody for Cav-1
and paxillin or for transmission electron microscopy analysis.
The percentage of Cav-1 polarization was calculated.
Adenovirus Production, Amplification, and Purification—
FLAG-tagged normal and mutant cDNA of Cav-1 were cloned
into pAdTrack-CMV, and the resultant constructs were
digested with PmeI and electrotransformed into BJ5183-AD-1competent cells for recombination. The recombinant adenoviral constructs were purified, digested with PacI, and transfected
into AD293 cells to produce the recombinant adenovirus. After
7–10 days, the primary adenovirus was generated. The recombinant adenoviruses were named AdCav1–178, AdCav61–178,
and AdCav46 –50A. AdCav1–178 expressed FLAG-tagged fulllength Cav-1 (Cav1–178-FLAG), and AdCav61–178 expressed
FLAG-tagged N-terminal deletion of Cav-1 (Cav61–178-FLAG).
AdCav46 –50A expressed Cav-1 with alanine substitution of aa
46 –50.
Upon reaching 90% confluency, AD293 cells were infected
with the primary adenovirus. The cells were then incubated at
37 °C for 48 h. Following incubation, the cells were collected
and suspended in 10 mM Tris-HCl (pH 7.9) buffer. Three
freeze/thaw cycles were performed at ⫺20 °C (until completely
frozen)/37 °C (until fully thawed). The debris was pelleted, and
supernatant was collected for purification. The adenovirus was
purified by sequential cesium chloride gradient centrifugation.
After purification, the virus was desalted and stored at ⫺80 °C.
Chemotaxis Dunn Chamber Assay—Cav-1 null MEFs
infected with AdCav1–178, AdCav61–178, or AdGFP were seeded
on a glass coverslip coated with 0.2% gelatin and starved for 4 h
prior to the assay. To set up gradient experiments, both concentric wells of the chamber were filled with starvation medium
(Dulbecco’s modified Eagle’s medium with 0.25% FBS), and a
coverslip seeded with cells was inverted onto the chamber in an
offset position leaving a narrow slit at one edge for refilling the
outer well. The medium of the outer well was drained and
replaced with Dulbecco’s modified Eagle’s medium supplemented with 10% FBS. For control experiments in which cells
were subjected to uniform concentrations of chemoattractant,
both wells were filled with medium containing 0.25% FBS.
The Horizon Method of Analyzing Chemotaxis—Cells
migrating over the annular bridge of the Dunn chamber were
recorded using a Zeiss LSM 510 laser-scanning confocal system
with 10⫻ objective. Differential interference contrast images
were captured at 2-min intervals for a total of 6 h using Zeiss
time-lapse software. Only cells migrating at least 20 m were
JOURNAL OF BIOLOGICAL CHEMISTRY
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included in the calculation. The “horizon” distance was defined
as the distance migrated from the starting position by 90% of
the cells, a value determined arbitrarily to enable a highly stringent statistical test. Cell trajectories from three independent
experiments were tracked manually and converted to a set of
angular directions (28). These angles were displayed in a circular histogram where the length of each 18° segment represented
the total number of cells with an average angle of migration
falling within that particular interval. The Rayleigh test for unimodal clustering of directions was used to determine whether
there was a significant chemotactic response (28). A uniform
distribution (random cell motility) of data was assumed if the p
value for the calculation was greater than 0.05. The mean direction is displayed as an arrow and the 95% confidence interval as
a gray arc (Fig. 8A).
Immunofluorescence Microscopy—Cells expressing GFPtagged normal or mutant forms of Cav-1 were plated on 0.2%
gelatin-coated glass coverslips to allow migration, fixed with 2%
paraformaldehyde in phosphate-buffered saline for 20 min at
22 °C, and then either mounted with Fluoromount-G (Southern Biotech Inc.) directly or permeabilized with 0.5% (v/v) Triton X-100 for 10 min at 22 °C. The permeabilized cells were
blocked with 5% normal goat serum in phosphate-buffered
saline for 1 h at 22 °C and incubated with primary antibody for
1 h followed by rhodamine Red-X-conjugated secondary antibody. Fluorescence images of the cells were acquired on an
upright Carl Zeiss LSM 510 confocal microscope equipped with
C-Apochromat 40⫻/1.2 W water-immersion objective using
the 488 nm line of an argon laser and/or the 543 nm line of a
HeNe laser at 25 °C. Cell borders were outlined from differential interference contrast images.
Images of 30 – 40 polarized cells expressing Cav-1-GFP were
randomly recorded. Green fluorescence intensity in six regions
(three at the cell front and three at the cell rear; see Fig. 2B) of
each cell was measured using Image J software. Cav-1 depolarization was assumed if a ratio of rear-to-front fluorescence
intensity was equal to or less than the cells expressing GFP. If a
ratio of rear-to-front fluorescence intensity of a Cav-1 mutant
was significantly higher than the cells expressing GFP but less
than wild-type Cav-1 (Cav1–178-GFP), a partial polarization was
assumed. We have shown that loss of Cav-1 polarity affects cell
polarization (24). In the present study, we focused only on the
polarized subpopulation of the cells to determine the polarity of
Cav-1 mutants (see “Results”).
Immunoprecipitation and Immunoblot Analysis—Cav61–178GFP or Cav61–178-FLAG was expressed in Cav-1⫺/⫺ MEFs, and
the cells were lysed in ice-cold lysis buffer containing 1% Triton
X-100, 0.5% Nonidet P-40, 60 mM octylglucoside, 1 mM EGTA,
and 10 mM Tris-HCl (pH 7.4) supplemented with protease
inhibitors. The lysates were precleared and immunoprecipitated with polyclonal GFP antibodies or monoclonal antiFLAG M2 antibodies at 4 °C. Immunoprecipitates were boiled
for 4 min in Laemmli sample buffer. The samples were separated by SDS-PAGE on a 12% gel, electrotransferred to a nitrocellulose membrane, and immunoblotted against Cav-1. Bands
were visualized by SuperSignal West Pico chemiluminescent
substrate (Pierce).
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Purification of Caveolin-rich Membrane Domains—Caveolin-rich membrane domains were isolated as described previously (29). In brief, confluent cells were scraped into sodium
carbonate (pH 11.0) and homogenized. The resulting homogenate was mixed with the same volume of 90% sucrose in MESbuffered saline, which was overlaid by 35 and 5% sucrose in
MES-buffered saline. The gradient was then centrifuged at
39,000 rpm for 16 h in an SW41 rotor, and then 12 fractions of
1 ml in each were collected, starting from the top of the gradient, for immunoblot analysis.
Transmission Electron Microscopy—Cav-1⫺/⫺ MEFs were
infected with or without AdCav1–178 or AdCav61–178. Twentyfour hours post-infection, cells were seeded onto gelatin-coated
dishes, fixed with 4% paraformaldehyde and 0.25% glutaraldehyde in phosphate buffer, and scraped into a microcentrifuge
tube. The samples were post-fixed with osmium tetroxide and
then embedded in epon. The sections were stained with uranyl
acetate and lead citrate. Thin sections of samples were examined under a JEOL 1220 transmission electron microscope.

RESULTS
Deletion of aa 1– 60 at the N Terminus Prevents Rear Polarization of Caveolin-1—Upon cell migration, Cav-1 is excluded
from the leading edge and polarized to the cell rear. On the basis
of previous extensive studies to identify domains that dictate
caveolin intracellular trafficking, we reasoned that when cells
are stimulated to migrate, Cav-1 moves to the rear of migrating
cells in a sequence-specific fashion as a mechanism to sequester
it away from signaling proteins that direct lamellipod protrusion. To determine the amino acid sequence that is necessary
for Cav-1 polarization, we started by generating a series of
caveolin-1 mutants by deletion mutations across the molecule,
because this strategy had been used successfully to characterize
domains for caveolar membrane targeting and intracellular
trafficking (22, 23, 30 –32). To assess the trafficking of Cav-1
mutants, we chose Cav-1⫺/⫺ cells that were deficient in endogenous Cav-1 and would not sequester the mutants and keep
them from depolarizing (see Fig. 3). The deletion mutants used
in the present study include Cav32–178, Cav61–178, and Cav1–156
(Fig. 1). Previous studies have shown that deletion of aa 60 – 80
results in trapping the molecule in the endoplasmic reticulum
(ER), whereas deletion of either aa 80 –100 or 134 –154 leads to
co-localization with a Golgi marker (22). Thus, Cav-1 mutants
that have been shown previously to sort improperly after
expression were excluded from the present study. Wild-type
and mutant Cav-1 generated as GFP fusion proteins were transiently expressed in Cav-1⫺/⫺ MEFs and detected in a punctate
pattern on the plasma membrane and, to a lesser extent, in the
perinuclear regions (apparently the Golgi apparatus) in stationary cells (data not shown).
Our previous study showed that targeted knockdown of
Cav-1 using Cav-1 siRNA (small interfering RNA) impeded
human endothelial cell polarization by 3-fold and inhibited cell
directional movement (24). This result was confirmed by our
recent study demonstrating a dramatic decrease in the number
of polarized mouse pulmonary endothelial cells from 32 ⫾ 3.8%
in wild-type cells to 16 ⫾ 3.5% in Cav-1⫺/⫺ cells (p ⬍ 0.01),
suggesting that Cav-1 polarity plays an important role in cell
VOLUME 282 • NUMBER 10 • MARCH 9, 2007
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FIGURE 1. Schematic representation of wild-type and mutant Cav-1. Nine
different Cav-1 constructs were used in this study. Cav-1 is divided into three
domains. The N terminus (residues 1–101) and C terminus (residues 135–178)
are separated by a hydrophobic transmembrane domain (TM; residues 102–
134). Full-length and mutant Cav-1 were fused with GFP. The location of the
alanine substitutions in each construct (Cav32–35A-GFP to Cav51–55A-GFP) is
indicated by a black box. The ability of the constructs to polarize in migrating
Cav-1⫺/⫺ MEFs is indicated in the column to the right of each construct.

polarization. Although the number of polarized cells was dramatically reduced, some Cav-1 depolarized cells were able to
polarize, suggesting that Cav-1 depolarization was not sufficient to completely block cell polarization. Thus, we expected
that ectopic expression of full-length Cav-1 in Cav-1⫺/⫺ cells
would restore cell polarization and that expression of Cav-1
mutants would impede cell polarization and, subsequently, the
polarity of the Cav-1 mutants. Therefore, in the present study,
we focused only on the polarized subpopulation of cells to
determine the polarity of Cav-1 mutants.
Consistent with previous observations (24, 25), Cav1–178GFP polarized at the rear of migrating Cav-1⫺/⫺ MEFs (Fig. 2A,
a), suggesting that exogenously expressed Cav-1 behaves as
endogenous protein and is able to polarize in Cav-1-deficient
cells. Deletion of aa 1–31 retained Cav-1 rear polarity. In contrast, deletion of aa 1– 60 (Cav61–178-GFP) prevented rear
polarization of the protein, and instead signals of the mutant
were detected at the leading edge (Fig. 2A, d), suggesting that aa
32– 60 are necessary for Cav-1 polarization.
To assess whether the C-terminal domain plays a role in
Cav-1 polarization, Cav-1⫺/⫺ MEFs were transfected with a
Cav-1 mutant lacking the final 22 amino acids (Cav1–156-GFP).
As shown in Fig. 2A, c, the mutant polarized at the cell rear. In
addition, weak signals were detected at the cell front, suggesting
a partial polarization of the mutant.
To analyze the polarized Cav-1-GFP signal statistically in
migrating cells, fluorescence intensity in six regions (three at
the cell front and three at the cell rear; see Fig. 2B) was detected,
and a ratio of rear-to-front fluorescence intensity was determined in each mutant (n ⱖ 30) (see “Experimental Procedures”) and compared with GFP only. Statistical analysis
revealed that the ratio of rear-to-front fluorescence intensity in
Cav1–178-GFP- or Cav32–178-GFP-expressing cells was 2.6- or
2.3-fold more than that in GFP, respectively (p ⬍ 0.0001; Table
1, Fig. 2C), suggesting that deletion of the first 31 aa at the N
MARCH 9, 2007 • VOLUME 282 • NUMBER 10

FIGURE 2. Deletion of the N terminus of Cav-1 prevents polarization of the
protein. A, Cav-1⫺/⫺ MEFs were transfected with the constructs expressing
Cav1–178-GFP (a), Cav32–178-GFP (b), Cav1–156-GFP (c), Cav61–178-GFP (d), or GFP
alone (e). Twenty-four hours post-transfection, cells were seeded to allow
migration, fixed with 2% paraformaldehyde and examined by confocal fluorescence microscopy (a– c, cell borders are outlined by a white line). Note that
Cav1–178-GFP (a) and Cav32–178-GFP (b) polarize in Cav-1⫺/⫺ MEFs. In contrast,
deletion of the first 60 amino acids at the N terminus (d) prevents the protein
from polarization, and the mutant signal is detected at the leading edge. Scale
bar, 20 m. B and C, images of polarized cells expressing either full-length or
mutant Cav-1 were randomly recorded, and the fluorescence intensity in six
regions (three at the cell front (F1–F3) and three at the cell rear (R1–R3)) (B) was
measured as described under “Experimental Procedures.” A ratio of rear-tofront fluorescence intensity in each mutant was determined (C). Data are the
mean ⫾ S.E. from three independent experiments. Statistical analysis is
shown in Table 1. *, p ⬍ 0.01 compared with GFP only; **, p ⬍ 0.01 with
full-length Cav-1 (Cav1–178-GFP). D, the number of Cav-1 polarized cells was
determined by comparing the ratio of rear-to-front fluorescence intensity in
each mutant with that of GFP. Polarization of a Cav-1 mutant was assumed if
fluorescence intensity ratio of the mutant was higher than 2 S.D. of the mean
of GFP. Data are the mean ⫾ S.E. from three independent experiments. E, a
parallel set of the cells transfected with the constructs described in A were
lysed, and the lysates were subjected to SDS-PAGE and Western blotting with
antibody for GFP and GAPDH.

TABLE 1
Student’s t test analysis of the fluorescence intensity of Cav-1
deletion mutants
Construct
Cav1–178-GFP
Cav32–178-GFP
Cav61–178-GFP
Cav1–156-GFP

p value
compared with Cav1–178-GFP

p value
compared with GFP

0.276
8.858 ⫻ 10⫺9
2.016 ⫻ 10⫺4

6.640 ⫻ 10⫺9
1.540 ⫻ 10⫺6
0.724
5.407 ⫻ 10⫺5
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terminus does not affect the polarity of the protein. In contrast,
deletion of an additional 29 aa dramatically reduced the fluorescence intensity ratio to the level of GFP, suggesting loss of
polarity (Fig. 2C). The fluorescence intensity ratio in Cav1–156GFP was 1.6-fold higher than GFP (p ⬍ 0.01) but 1.6-fold lower
than Cav1–178-GFP (p ⬍ 0.01), indicating partial polarization
(Table 1; Fig. 2C). The effect of deletion mutation on Cav-1
polarization was not due to protein expression levels (Fig. 2E).
The number of Cav-1-polarized cells expressing each construct
was determined by comparing the ratio of rear-to-front fluorescence intensity in each mutant with that of GFP. As described
above, we focused only on the polarized subpopulation of the
cells. Polarization of a Cav-1 mutant was assumed if fluorescence intensity ratio of the mutant was more than 2 S.D. of the
mean of GFP. Fig. 2D shows that 79.5 ⫾ 5.7% of morphologically polarized cells expressing full-length Cav-1 display Cav-1
rear polarization. In contrast, up to 8.8 ⫾ 0.25% of polarized
cells expressing Cav61–178-GFP show rear polarization. The
number of Cav-1 rear polarization cells is 44 ⫾ 5.5% of polarized cells expressing the partial polarity mutant, Cav1–156-GFP.
Cav61–178-GFP Regains Polarity by Interacting with Endogenous Caveolin-1—Cav-1 exists as a high molecular mass in
living cells, which is mediated by the oligomer domain, aa
61–101 (33). It is possible that expression of the depolarization mutant Cav61–178-GFP would affect the localization of
endogenous Cav-1 in a migrating cell. To test this hypothesis,
we expressed Cav61–178-GFP in either HUVECs or wild-type
MEFs known to express Cav-1 and examined the localization of
endogenous Cav-1 using polyclonal antibody for Cav-1 (the
antibody recognizes an epitope at the N terminus of Cav-1 and
does not react with our depolarization mutant). Fig. 3A shows
that the depolarization mutant Cav-1 is co-localized with
endogenous Cav-1, and interestingly, the mutant is polarized
together with wild-type Cav-1 at the cell rear. This result suggests that the mutant may be trapped and co-translocated with
endogenous Cav-1 to the rear of migrating cells.
To assess whether the mutant interacted with endogenous
Cav-1, wild-type MEFs were transfected with or without the
depolarization construct expressing Cav61–178-GFP and subjected to immunoprecipitation with specific antibody for GFP.
As shown in Fig. 3B, endogenous Cav-1 is co-precipitated with
Cav61–178-GFP (monoclonal antibody (clone 2297) recognizes
an epitope within aa 61–71 (34), and reacts with the depolarization mutant, Cav61–178-GFP). To confirm this result, we
generated an adenovirus harboring FLAG-tagged mutant
Cav-1 (Cav61–178-FLAG). Wild-type MEFs were infected
with the adenovirus and subjected to immunoprecipitation
with an antibody specific for FLAG. Again, endogenous
Cav-1 was detected in the immunoprecipitation complex
(Fig. 3B), suggesting an interaction between the mutant and
endogenous Cav-1.
Caveolin-1 is a principal protein component of caveolar
membranes and resists solubilization in nonionic detergents at
cold temperatures (35, 36). This physical property reflects
enrichment of cholesterol and glycosphingolipids in caveolae
(17). To determine whether Cav61–178 was tightly associated
with lipid rafts, HUVECs were infected with AdCav61–178 and
extracted with alkaline sodium carbonate, an agent that strips
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FIGURE 3. Cav61–178-GFP becomes polarized in cells expressing endogenous Cav-1. A, HUVECs (a– c) or wild-type MEFs (d–f) were transfected with a
construct expressing Cav61–178-GFP. Twenty-four hours post-transfection,
cells were seeded to allow migration, fixed, and stained with antibody for
Cav-1 followed by rhodamine Red-X-conjugated secondary antibody. Note
that Cav61–178-GFP (a and d) is co-localized with endogenous Cav-1 and
becomes polarized in HUVECs as well as wild-type MEFs. Scale bar ⫽ 20 m.
B, wild-type MEFs were transfected with a construct expressing Cav61–178-GFP
(a) or infected with adenovirus harboring FLAG-tagged Cav61–178 (Cav61–178Flag) (b). After 24 h, cells were lysed, and the lysates were subjected to immunoprecipitation (IP) with antibody for either GFP or FLAG followed by SDSPAGE and immunoblotting (IB) with specific antibody for Cav-1.

FIGURE 4. Association of Cav61–178 with caveolin-rich membrane
domains. Twenty-four hours post-infection of HUVECs with adenovirus harboring Cav61–178 (AdCav61–178) or Cav-1⫺/⫺ MEFs with either AdCav1–178 or
AdCav61–178, low density membrane domains were isolated using a detergent-free method (see “Experimental Procedures”). After sucrose gradient
ultracentrifugation, 12 fractions were collected. Equal volume aliquots of
each fraction were subjected to SDS-PAGE and immunoblotted with specific
antibody for Cav-1. Note that Cav61–178 is co-fractionated with endogenous
Cav-1 at fraction 5 from HUVECs. In Cav-1⫺/⫺ MEFs, Cav61–178 is targeted to
the light density membrane domains.

membranes of peripherally associated proteins, followed by an
established sucrose density centrifugation method to purify
caveolae microdomains (37, 38). Fig. 4 shows that Cav61–178 is
co-fractionated with endogenous Cav-1 (fraction 5, top panel).
To assess whether the association with caveolae membranes
resulted from its interaction with endogenous Cav-1, Cav-1⫺/⫺
MEFs were infected with either AdCav1–178 or AdCav61–178,
and caveolae were isolated. We found that most of the
mutant protein was recovered in fractions 5–7, indicating an
integration of the mutant itself into lipid rafts (Fig. 4, lower
panel).
Deletion of aa 1– 60 Impedes Caveolae Formation—Cav-1 is a
known critical factor required for biogenesis of caveolae. Cav-1
is a cholesterol-binding protein and may facilitate the concentration of a critical mass of cholesterol required for caveolae
VOLUME 282 • NUMBER 10 • MARCH 9, 2007
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depolarized in cells expressing the
depolarization mutant, Cav-1⫺/⫺
MEFs were infected with adenovirus harboring either wild-type
(AdCav1–178) or the mutant Cav-1
(AdCav61–178) and processed for
transmission electron microscopy.
Fig. 5A shows that expression of
wild-type Cav-1 induces caveolae
formation, which localizes abundantly at the rear of a migrating
cell as we have demonstrated previously (24). Surprisingly, expression of the depolarization mutant
Cav-1 dramatically decreased the
number of cells that were induced
to form caveolae, by more than
12-fold (Fig. 5B). Furthermore, the
number of caveolae in each cell
was dramatically decreased by up
to 4-fold (Fig. 5C). The impairment of caveolae formation did
not result from protein expression
levels (Fig. 5D). Because few
caveolae were formed by the depolarization mutant, we were not
able to determine whether caveolae were polarized in these cells.
Identification of the Minimal
Amino Acid Sequence Required for
Caveolin-1 Polarization—Our results thus indicate that aa 32– 60
FIGURE 5. Deletion of aa 1– 60 impedes caveolae formation. A, Cav-1⫺/⫺ MEFs were infected with either are critical for the rear polarizaAdCav61–178 (a– c) or AdCav1–178 (d and e) or were mock infected (f). Twenty-four hours post-infection, cells
were fixed and processed for transmission electron microscopy. As expected, there was no caveolar structure tion of Cav-1. To identify the minin Cav-1⫺/⫺ cells (f). In contrast, transduced expression of wild-type Cav-1 (d and e) resulted in caveolae imal sequence that is necessary for
formation (arrows). Interestingly, deletion of the first 60 aa led to a dramatic reduction in caveolae formation Cav-1 polarization, we generated a
(arrows in a– c). b, c, and e are images at higher magnification of images a and d, respectively. Scale bars: 100 nm
for b, c and e; 2 m for a, , and f. B and C, images were randomly recorded; 90 (AdCav1–178-infected) or 198 series of consecutive quadro- or
(AdCav61–178-infected) cells were viewed. The number of cells that contained caveolae (B) and the number of penta-alanyl codon substitutions
caveolae in each cell (C) were counted. Data are the mean ⫾ S.E. from three independent experiments. *, p ⬍
from aa 32 to 55 (Fig. 1) and exam0.05. D, 24 h post-infection, a parallel set of cells was lysed and subjected to SDS-PAGE and Western blotting
with antibody for Cav-1. The same membrane was reprobed with antibody for GAPDH to show equal protein ined the localization of the
loading.
mutants by fluorescence microscopy (Fig. 6). Substitution of aa
invagination. Overexpression of Cav-1 in a lymphocytic cell 32– 40 with alanine (Cav32–35A-GFP, Cav36 – 40A-GFP) did
line that does not endogenously express the protein and lacks not affect Cav-1 polarity (Fig. 6A, a and b). Substitution of aa
caveolae is sufficient to induce the formation of caveolae (39). 41– 45 with alanine (Cav41– 45A-GFP) led to partial polarizaGenetic ablation of Cav-1 generates animals that lack caveolae tion of Cav-1 (c in Fig. 6A). In clear contrast, replacement of
(40, 41).
aa 46 –55 with alanine (Cav46 –50A-GFP, Cav51–55A-GFP)
Upon the discovery of their abundance in endothelium, prevented the rear polarization of Cav-1 (Fig. 6A, d and e).
caveolae have been postulated as vesicular carriers mediatStatistical analysis revealed that the ratio of rear-to-front fluing endocytosis and transcytosis (7, 42). Indeed, caveolae orescence intensity in Cav46 –50A-GFP- and Cav51–55A-GFP-exhave the molecular transport machinery for vesicle budding, pressing cells was similar to GFP but was reduced by 3-fold
docking, and fusion (43). Thus, at least in endothelium, compared with full-length Cav-1 (Cav1–178-GFP) (p ⬍ 0.0001)
caveolae may integrate signaling events with vesicular trans- (Table 2; Fig. 6B). The fluorescence intensity in Cav41– 45A-GFP
port (44). We and others have shown that concomitant with was about 1.5-fold higher than GFP (p ⬍ 0.05) but 2-fold lower
Cav-1 polarization, caveolae move to cell posterior as well than Cav1–178-GFP (p ⬍ 0.0001), indicating partial polarization
(24, 25), suggesting that caveolae may function as transport (Table 2; Fig. 6B). Thus, we have identified a sequence motif in
cargos carrying Cav-1 to cell rear. To test whether aa 1– 60 of Cav-1, 46TKEIDLVNRD55, that is essential for the rear polarCav-1 affect caveolae formation and whether caveolae are ization of the protein in migrating cells. The effect of alanine
MARCH 9, 2007 • VOLUME 282 • NUMBER 10
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TABLE 2
Student’s t test analysis of the fluorescence intensity of alanine
replacement mutants

FIGURE 6. Amino acids 46 –55 are required for Cav-1 rear polarization.
A, Cav-1⫺/⫺ MEFs were transfected with constructs with a series of consecutive quatra- or penta-alanine substitutions between aa 32 and 55 of
Cav-1. Twenty-four hours post-transfection, cells were seeded to allow
migration, fixed, and examined by confocal fluorescence microscopy (a, b,
and f, cell borders are outlined in white). Note that substitution of amino
acids 46 –50 or 51–55 (d and e) with alanine prevents Cav-1 polarization.
Scale bar, 20 m. B, images of polarized cells expressing Cav-1 mutants (n ⱖ
30 for each construct) were randomly recorded. Fluorescence intensity in six
regions was measured, and a ratio of rear-to-front fluorescence intensity in
each mutant was determined as described in the legend to Fig. 2B. Data are
the mean ⫾ S.E. from three independent experiments. Statistical analysis is
shown in Table 2. *, p ⬍ 0.05 compared with GFP only; **, p ⬍ 0.01 with
full-length Cav-1 (Cav1–178-GFP). C, the number of Cav-1 polarized cells was
determined as described in the legend to Fig. 2. Data are the mean ⫾ S.E. from
three independent experiments. D, a parallel set of the cells transfected with
the constructs as in A was lysed, and the lysates were subjected to SDS-PAGE
and Western blotting with antibody for GFP and GAPDH. E, Cav-1⫺/⫺ MEFs
were infected with either AdCav1–178 or AdCav46 –50A. Twenty-four hours
post-infection, cells were fixed and processed for transmission electron
microscopy. Images were randomly recorded; 40 (AdCav1–178-infected) or 68
(AdCav46 –50A-infected) cells were viewed. The number of cells that contained
caveolae (a) and the number of caveolae in each cell (b) were counted. Data
are the mean ⫾ S.E. from two independent experiments. *, p ⬍ 0.05. Twentyfour hours post-infection, a parallel set of cells was lysed and subjected to
SDS-PAGE and Western blotting with antibody for Cav-1 (c). The same membrane was reprobed with antibody for GAPDH to show equal protein loading.

substitution on Cav-1 polarization was not due to protein
expression levels (Fig. 6D).
The number of Cav-1-polarized cells expressing each construct
was determined as described above. Polarization of a Cav-1
mutant was assumed if the fluorescence intensity ratio of the
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Construct

p value
compared with Cav1–178-GFP

p value
compared with GFP

Cav32–35A-GFP
Cav36–40A-GFP
Cav41–45A-GFP
Cav46–50A-GFP
Cav51–55A-GFP

0.226
0.203
3.799 ⫻ 10⫺6
2.629 ⫻ 10⫺8
3.935 ⫻ 10⫺9

3.215 ⫻ 10⫺6
8.150 ⫻ 10⫺6
0.016
0.135
0.392

mutant was more than 2 S.D. of the mean of GFP. Fig. 6C shows
that about 65% of the polarized cells expressing Cav32–35A-GFP
or Cav36 – 40A-GFP display Cav-1 rear polarization. In contrast,
about 15% of the polarized cells expressing Cav46 –50A-GFP or
6.4% of the polarized cells expressing Cav51–55A-GFP show rear
polarization. The number of Cav-1 rear polarization cells is
about 41% of polarized cells expressing Cav41– 45A-GFP.
To assess whether the alanine substitution mutants affect
caveolae formation, Cav-1⫺/⫺ MEFs were infected with adenovirus harboring either wild-type (AdCav1–178) or an alanine substitution of aa 46 –50 mutant (AdCav46 –50A) and
processed for transmission electron microscopy. As shown
in Fig. 6E, substitution of aa 46 –50 with alanine dramatically
decreased (by 5-fold) the number of cells that were induced
to form caveolae (Fig. 6E, a). Furthermore, the number of
caveolae in each cell was dramatically decreased by 3.5-fold
(Fig. 6E, b). The impairment of caveolae formation did not
result from protein expression levels (Fig. 6E, c). Thus, these
results suggest that aa 46 –50 play important role in Cav-1
polarity and caveolae formation.
Loss of Caveolae Fails to Prevent Cav-1 Polarization—The
observation that mutation of aa 46 –50 coincidentally blocked
Cav-1 polarization as well as caveolae formation is interesting
and suggests that: 1) Cav-1 polarity is caveolae-dependent, or 2)
the sequence motif is required both for Cav-1 polarization and
caveolae formation. To test these hypotheses, we employed an
alternative model by treating wild-type MEFs with M␤CD to
reduce cellular cholesterol level, which is known to block
caveolae formation (45) and disperse Cav-1 in the plasma membranes (27). In the absence of M␤CD, more than 50% of the
MEFs examined showed caveolae structure, and the number of
caveolae in those cells was about 14 caveolae/cell. Treatment of
the cells with 10 mM M␤CD dramatically suppressed the number of cells containing caveolae by more than 3.5-fold and the
number of caveolae by 4.5-fold (Fig. 7A). However, the loss of
caveolae formation failed to prevent Cav-1 rear polarization
(Fig. 7, B and C). Thus, these results suggest that a caveolaeindependent mechanism may mediate Cav-1 rear polarization.
Caveolin-1 Polarity Plays an Important Role in Cell Directional Movement—The generation of Cav-1 null cells provided
a genetic model of Cav-1 depolarization and was used to test
their ability to migrate directionally toward chemoattractant
(10% FBS) using a well characterized chemotaxis Dunn chamber (28). In this system, cells were viewed directly and recorded
over a 6-h period by a live cell time-lapse imaging system. Only
cells migrating at least 20 m (the “horizon” distance) were
included in the calculation (see “Experimental Procedures”).
Cell trajectories from three independent experiments were
tracked manually, converted to a set of angular directions, and
VOLUME 282 • NUMBER 10 • MARCH 9, 2007
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FIGURE 7. Knockdown of caveolae does not affect Cav-1 polarity. A, wildtype MEFs were treated with 0 or 10 mM M␤CD for 30 min, fixed, and then
processed for transmission electron microscopy. The number of cells containing caveolae and the number of caveolae in those cells were counted. Note
that M␤CD treatment dramatically reduces caveolae numbers. Data are the
mean ⫾ S.D. *, p ⬍ 0.05. B and C, after treatment with 0 (a), 3 (b), or 10 (c) mM
M␤CD, wild-type MEFs were fixed and stained with antibody for Cav-1 (B).
Dotted lines indicate cell borders. Images were randomly recorded, and the
number of Cav-1 polarized cells was counted (C). Note that knockdown of
caveolae by M␤CD does not affect Cav-1 polarization. Data are the mean ⫾
S.D. D, a parallel set of the cells pretreated with M␤CD as described in B was
lysed, and cell lysates were subjected to SDS-PAGE and Western blot analysis
with antibody for Cav-1.

displayed in a circular histogram (Fig. 8A). The majority of Cav1-deficient cells demonstrated disorientated migration (Fig.
8A, a). To test the effect of the depolarization mutant Cav-1 on
chemotaxis, we infected Cav-1⫺/⫺ MEFs with the adenovirus
harboring full-length Cav-1 (Cav1–178), the depolarization
mutant Cav-1 (Cav61–178), or GFP only. The expression levels of
the full-length and the depolarization mutant Cav-1 were similar to the level of wild-type MEFs (Fig. 8C). Interestingly,
expression of full-length Cav-1 in the Cav-1⫺/⫺ cells resulted in
up-gradient directional migration (Fig. 8A, b). In contrast,
expression of the depolarization mutant, Cav-1, was not able to
rescue the disoriented migration of the Cav-1⫺/⫺ cells (Fig. 8A, c),
thus suggesting that the rear polarization of Cav-1 plays an important role in chemotaxis. Quantitative analysis shows that expression of full-length Cav-1 caused more than 80% cells to migrate
toward serum, whereas cells expressing GFP or the depolarization
mutant showed negligible chemotactic movement (Fig. 8B).

DISCUSSION
Cell migration involves the asymmetrical organization of
plasma membrane features that are associated with the
MARCH 9, 2007 • VOLUME 282 • NUMBER 10

FIGURE 8. Caveolin-1 polarity plays an important role in cell directional
movement. A, Cav-1⫺/⫺ MEFs were infected with adenovirus expressing GFP
only (AdGFP) (a), full-length Cav-1 (AdCav1–178) (b and d), or the depolarization mutant (AdCav61–178) (c). The directional migration of the cells was analyzed using a chemotaxis Dunn chamber. Cells were exposed to either a gradient from 0.25% to 10% FBS (a– c) or no gradient (0.25% FBS in both
chambers) (d). The direction of the gradient is indicated by the arrow in e. The
data are presented as a circular histogram in which the length of each 18o
segment (as shown in f) represents the number of cells with an average angle
of migration falling within that particular interval (see “Experimental Procedures”). The mean direction of chemotaxis is displayed as an arrow, and the
95% confidence interval as a gray arc. B, quantitative analysis of cell directional movement. The number of chemotactic cells was determined by
counting the cells with net movement toward serum gradient (these include
the cells in the segments between 0 and 90o and 270 and 360o (see A, panel e).
Note that Cav-1⫺/⫺ MEFs expressing GFP or the depolarization mutant show
negligible chemotactic movement. Data are the mean ⫾ S.D. *, p ⬍ 0.05
compared with GFP. C, Cav-1⫺/⫺ MEFs were infected with AdCav1–178,
AdCav61–178, or AdGFP. Twenty-four hours post-infection, cells were lysed,
and the lysates were subjected to SDS-PAGE and immunoblotting with antibody for Cav-1. The same membrane was reprobed with antibody for GAPDH
to show equal protein loading. WT, wild type.

cytoskeleton and signaling molecules. We and other groups
have recently shown that Cav-1 was specifically polarizes to the
posterior of migrating cells (22, 24, 25). In the present study, we
systematically identified and characterized a domain at the N
terminus of Cav-1 that controls rear polarization of the protein.
Previous studies have identified a number of functional elements in caveolin. These include identification of the caveolin
scaffolding domain that interacts with multiple signaling molecules (46, 47); the segment that is involved in self-association
to form oligomers (33); the Golgi and ER localization signals
(22, 23); the caveolin-inhibitory domain that inhibits endotheJOURNAL OF BIOLOGICAL CHEMISTRY
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lial nitric-oxide synthase, c-Src, and protein kinase A (48, 49);
and the N- and C-terminal membrane attachment domains (31,
32). These investigations have employed cell systems that
express endogenous Cav-1. Evidence has shown that interaction between the transduced and endogenous Cav-1 may mask
crucial trafficking information (Ref. 50 and our present study
on HUVECs and wild-type MEFs). The success of the present
study depended on employing a cell system that was genetically
deficient in Cav-1. Using this system, we have identified a
sequence motif, aa 46 –55, that is essential for Cav-1 rear polarization and caveolae formation in migrating cells.
The observations that deletion of aa 1– 60 or mutation of aa
46 –50 coincidentally blocked Cav-1 polarization as well as
caveolae formation suggest that Cav-1 polarity may be caveolaedependent. This idea is consistent with caveolae functioning as
transport cargos carrying Cav-1 to the rear of the cell. Thus, the
mutation-induced Cav-1 depolarization may be indirect and
may result from a loss of caveolae structure. We tested this
hypothesis by depletion of cholesterol to block caveolae formation (45) and found that loss of caveolae failed to prevent the
polarization of endogenous full-length Cav-1. Taken together,
our results suggest that Cav-1 polarity appears to be mediated
by 1) caveolae and/or 2) a sequence motif at the N terminus of
the protein.
Multiple sequence alignment of Cav-1, -2, and -3 shows that
the sequence from aa 47 to 56 is 100% identical between Cav-1
and Cav-3 (16), suggesting that this segment may mediate common functions shared by the two proteins. Another N-terminal
conserved sequence, designed as the signature domain, is aa
68 –75, which contains the sorting signal (aa 66 –70) responsible for exit from the ER (22). The sequence of aa 46 –55 does not
resemble any domain with known function. Thus, the conserved sequence represents a novel domain that dictates subcellular translocation of Cav-1. We propose the term N-CPD
(N-terminal caveolin polarity domain). The N-terminal (aa
1–79) and C-terminal (122–178) tails of Cav-1 are believed to
be unstructured hydrophilic tails that remain entirely cytosolic
and are accessible for cytosolic protein interactions (16). Thus,
N-CPD might interact with an unidentified factor(s) that controls Cav-1 polarization in migrating cells.
When expressed either in HUVECs or wild-type MEFs that
express endogenous Cav-1, deletion of N-CPD failed to prevent
the mutant Cav-1 from polarization. This was not surprising,
given the nature of caveolin and caveolin self-interaction (via aa
61–101) to form homo-oligomers before incorporation into
glycosphingolipid-rich membranes in the Golgi apparatus (19).
Indeed, our present results show that the depolarization
mutant co-localizes and interacts with endogenous Cav-1.
These results are consistent with previous observations indicating that the deletion and alanine substitution mutants retain
the same orientation with wild-type Cav-1, have relatively normal confirmation, and are not shunted into a degradation pathway (22). Furthermore, the mutant is tightly associated with
lipid rafts. Surprisingly, deletion of aa 1– 60 or mutation of aa
46 –50 dramatically impeded caveolae formation. This was
likely not caused by the interruption of the binding between
Cav-1 and cholesterol, because this mutant contains the putative free cholesterol-binding sequence (94VTKYWFYR101)
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(51). The results suggest that aa 46 –50 may play a role in caveolae formation.
In the present study, we found that when expressed in MEFs,
the majority signals of our depolarization mutant, Cav61–178GFP, which lacked the first 60 aa, localized in a punctate pattern
on the plasma membrane and, to a lesser extent, in the Golgi
apparatus. Similarly, Machleidt et al. (22) recently showed
plasma membrane targeting of the same mutant that lacked the
first 59 aa, Cav60 –178, when it was expressed in CHO cells. A
recent study showed that expression of a deletion mutant that
lacked the first half of the N-terminal domain (aa 3– 48) in
Fischer rat thyroid cells resulted in the accumulation of the
mutant in the Golgi apparatus, although it oligomerized normally and associated with lipid rafts (30). The difference apparently resulted from the cell types used for protein expression.
For instance, Fischer rat thyroid cells are likely to exhibit more
pronounced Golgi apparatus staining of ectopically expressed
proteins, such as full-length Cav-1, than other types of the cells
that express Cav-1 endogenously, suggesting that Fischer rat
thyroid cells are more sensitive to the conformational changes
of Cav-1 (52).
Mutagenesis and biochemical analysis suggest that Cav-1 is
cycling between caveolae and intracellular compartments. The
transport depends on critical elements in the molecule required
for the proper targeting to intracellular compartments (22, 23,
53). One of the functions of Cav-1 trafficking appears to the
maintenance of cholesterol homeostasis (21). Cav-1 binds
directly to and is tightly associated with free cholesterol (54),
and it travels between the ER and caveolae membrane as a cytosolic complex containing chaperone proteins and cholesterol
(55). Another lipid molecule in caveolae tightly associated with
Cav-1 is the glycosphingolipid GM1 (56). Thus, Cav-1, together
with caveolae (rich in cholesterol and glycosphingolipids), relocates to the cell posterior and provide a second function of
caveolin trafficking, i.e. establishment of cell membrane polarity in migrating cells. The polarized cholesterol and glycosphingolipids are likely to cause membrane stiffness and reduced
deformability at the cell rear (57). Indeed, our previous observation showed the absence of lamellipod protrusions where
Cav-1 was polarized (24).
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